Cargando…
Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is characterized by an abnormal and chronic inflammatory response in the lung that underlies the chronic airflow obstruction of the small airways, the inexorable decline of lung function, and the severity of the disease. The control of this inflammation r...
Autores principales: | Marwick, John A, Chung, Kian Fan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939685/ https://www.ncbi.nlm.nih.gov/pubmed/20856829 |
Ejemplares similares
-
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
por: Kaur, Manminder, et al.
Publicado: (2012) -
The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022) -
Targeted therapy in eosinophilic chronic obstructive pulmonary disease
por: Fieldes, Mathieu, et al.
Publicado: (2021) -
Oxidants Induce a Corticosteroid-Insensitive Phosphorylation of Histone 3 at Serine 10 in Monocytes
por: Marwick, John A., et al.
Publicado: (2015) -
Increased Interleukin-17 and Glucocorticoid Receptor-β Expression in Interstitial Lung Diseases and Corticosteroid Insensitivity
por: Lo, Chun-Yu, et al.
Publicado: (2022)